🇺🇸 US

NBIX earnings report dates and EPS history (Neurocrine Biosciences Inc)

Quick answer

Neurocrine Biosciences Inc (NBIX) reported diluted EPS of $1.39 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-07-31. Its last four 10-Q/10-K filings were on 2026-07-31, 2026-05-05, 2026-02-11, 2025-10-28.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2026-07-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Period endPeriodFormSEC filing dateDiluted EPS
2026-06-30Quarter10-Q2026-07-31$1.39
2026-03-31Quarter10-Q2026-05-05$1.91
2025-12-31Full year10-K2026-02-11$4.67
2025-09-30Quarter10-Q2025-10-28$2.04
2025-06-30Quarter10-Q2025-07-30$1.06
2025-03-31Quarter10-Q2025-05-05$0.08
2024-12-31Full year10-K2025-02-10$3.29
2024-09-30Quarter10-Q2024-10-30$1.24
2024-06-30Quarter10-Q2024-08-01$0.63
2024-03-31Quarter10-Q2024-05-01$0.42
2023-12-31Full year10-K2024-02-09$2.47
2023-09-30Quarter10-Q2023-10-31$0.82
2023-06-30Quarter10-Q2023-08-01$0.95
2023-03-31Quarter10-Q2023-05-03$-0.79
2022-12-31Full year10-K2023-02-09$1.56
2022-09-30Quarter10-Q2022-11-01$0.69

Related

Last updated 2026-10-16. Data only, not financial or tax advice.